Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Drug Name Analysis Includes Computer Tool To Spot Safety Problems

This article was originally published in The Pink Sheet Daily

Executive Summary

The program, still in development, is designed to detect look alike/sound alike names. Institute of Medicine Committee investigating medication errors may work in concert with new IoM committee on drug safety. FDA says it would welcome an IoM investigation into the effect of off-label drug use on medication errors.
Advertisement

Related Content

IoM Medication Errors Committee Should Estimate Cost Savings, CMS Says
IoM Medication Errors Committee Should Estimate Cost Savings, CMS Says
Janssen To Change Name Of Reminyl Products
Janssen To Change Name Of Reminyl Products
FDA Drug Safety Review Will Consider Pros And Cons Of Separate Safety Agency

Topics

Advertisement
UsernamePublicRestriction

Register

PS061049

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel